Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway

por Li, Yi-Jiong, Zhang, Guo-Ping, Zhao, Feng, Li, Rui-Qi, Liu, Shao-Jun, Zhao, Zeng-Ren, Wang, Xin
Publicado 2018